Publications by authors named "Mark Ashby"

Claim this Profile
I
In Reply: Feasibility of Endovascular Deep Brain Stimulation of Anterior Nucleus of the Thalamus for Refractory Epilepsy.
Varun Kashyap, Mark Ashby, Scott Stanslaski, Kevin Nguyen, Kristin Hageman

Oper Neurosurg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Endovascular Deep Brain Stimulation of Anterior Nucleus of the Thalamus for Refractory Epilepsy.
Varun Kashyap, Mark Ashby, Scott Stanslaski, Kevin Nguyen, Kristin Hageman

Oper Neurosurg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-perception and self-representation preference between 2-dimensional and 3-dimensional facial reconstructions among dentists, dental students, and laypersons.
Marta Revilla-León, Mark T Ashby, Matthew J Meyer, Amirali Zandinejad, Mikhail Umorin

J Prosthet Dent· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Layperson and Dental Professional Perception When Evaluating Their Own Virtually 2D or 3D Simulated Esthetic Discrepancies.
Marta Revilla-León, Mark T Ashby, Matthew J Meyer, Mikhail Umorin, Jennifer J Barrington

J Prosthodont· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.
Allen Kaplan, Dennis Ledford, Mark Ashby, Janice Canvin, James L Zazzali

J Allergy Clin Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of rituximab in combination with other biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: an open-label study.
William F C Rigby, Philip J Mease, Ewa Olech, Mark Ashby, Swati Tole

J Rheumatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.
Fairooz F Kabbinavar, Patrick J Flynn, Mark Kozloff, Mark A Ashby, Amy Sing

Eur J Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, open-label, single-arm study of tenecteplase for restoration of function in dysfunctional central venous catheters.
Cameron Tebbi, John Costanzi, Robert Shulman, Luke Dreisbach, Brian R Jacobs, Mark Ashby

J Vasc Interv Radiol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
Nashat Gabrail, Eric Sandler, Veena Charu, Nick Anas, Eduardo Lim, Mark Ashby

J Vasc Interv Radiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
Mark F Kozloff, Jordan Berlin, Patrick J Flynn, Fairooz Kabbinavar, Mark Ashby

Oncology· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
Mark Kozloff, Marianne Ulcickas Yood, Jordan Berlin, Patrick J Flynn, Fairooz F Kabbinavar, Mark A Ashby

Oncologist· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution, structure and diversity of "bacterial" genes encoding two-component proteins in the Euryarchaeota.
Mark K Ashby

Archaea· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyanobacterial two-component proteins: structure, diversity, distribution, and evolution.
Mark K Ashby, Jean Houmard

Microbiol Mol Biol Rev· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom control and improved functioning: the effect of omalizumab on asthma-related quality of life (ARQL).
Allan T Luskin, Mark Kosinski, Brian W Bresnahan, Mark Ashby, Dennis A Wong

J Asthma· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of acetyl phosphate on DspA signalling in the Cyanobacterium Synechocystis sp. PCC6803.
S Shawn Morrison, Conrad W Mullineaux, Mark K Ashby

BMC Microbiol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of the number of two-component response regulator genes in the complete and annotated genome sequences of prokaryotes.
Mark K Ashby

FEMS Microbiol Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
James L Gajewski, Gabriela Rondon, Michele L Donato, Paolo Anderlini, Martin Korbling, Mark Ashby

Biol Blood Marrow Transplant· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
Charles Linker, Paolo Anderlini, Roger Herzig, Neal Christiansen, George Somlo, Mark Ashby

Biol Blood Marrow Transplant· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.
Jonathan Corren, Thomas Casale, Yamo Deniz, Mark Ashby

J Allergy Clin Immunol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ycf27 genes from cyanobacteria and eukaryotic algae: distribution and implications for chloroplast evolution.
Mark K Ashby, Jean Houmard, Conrad W Mullineaux

FEMS Microbiol Lett· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac dysfunction in the trastuzumab clinical trials experience.
Andrew Seidman, Clifford Hudis, Mary Kathryn Pierri, Steven Shak, Virginia Paton, Mark Ashby

J Clin Oncol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis